石津洋二

イシヅヨウジ | Ishizu Yoji

所属機関・部署：

研究分野 (1件)：消化器内科学

競争的資金等の研究課題 (1件)：

2021 - 2024 サルコペニア患者に対する腸内細菌叢への介入による効果的な運動療法の開発

論文 (360件)：

Fumitaka Mizuno, Norihiro Imai, Kazuyuki Mizuno, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Hiroki Kawashima. Clinical Outcomes of Use of the Porous Glass Membrane Pumping Emulsification Device During Transarterial Chemoembolization for Hepatocellular Carcinoma. Anticancer research. 2024. 44. 7. 3185-3191
Masanao Nakamura, Takeshi Yamamura, Keiko Maeda, Tsunaki Sawada, Eri Ishikawa, Kentaro Murate, Kazuhiro Furukawa, Takashi Hirose, Kota Uetsuki, Tadashi Iida, et al. Long-term monitoring and clinical implications of small bowel capsule endoscopy in patients with Crohn's disease with small bowel lesions: A Retrospective Analysis. Digestion. 2024
Shinya Yokoyama, Takashi Honda, Yoji Ishizu, Norihiro Imai, Takanori Ito, Kenta Yamamoto, Kazuyuki Mizuno, Tetsuhito Kojima, Naoyoshi Kariya, Masanao Nakamura, et al. Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center. Clinical nutrition (Edinburgh, Scotland). 2024. 43. 6. 1425-1432
Yosuke Inukai, Kenta Yamamoto, Takashi Honda, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Masatoshi Ishigami, Hiroki Kawashima. Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular Carcinoma. Cancers. 2024. 16. 9
Takanori Ito, Kazuyuki Mizuno, Takafumi Yamamoto, Tsukasa Yasuda, Shinya Yokoyama, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Masayo Hama, et al. Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team. Hepatology research : the official journal of the Japan Society of Hepatology. 2024

MISC (81件)：

横山晋也, 石津洋二, 武藤久哲, 石上雅敏. 食道胃静脈瘤に対する内視鏡的静脈瘤治療後に菌血症および肝膿瘍を生じた小児の胆道閉鎖症の1例-Liver abscess with bacteremia following endoscopic variceal treatment in a child with biliary atresia : a case report. 日本門脈圧亢進症学会雑誌 = Japanese journal of portal hypertension / 日本門脈圧亢進症学会編. 2021. 27. 4. 302-308
Takashi Honda, None Yamada, Asako Murayama, Asuka Kato, Takanori Ito, Yoji Ishizu, Teiji Kuzuya, Masatoshi Ishigami, Yoshiki Murakami, Tetsuya Ishikawa, et al. AMINO ACID POLYMORPHISM IN HEPATITIS B VIRUS ASSOCIATED WITH NATURAL CLEARANCE OF HBV DNA AND HBsAg. HEPATOLOGY. 2020. 72. 508A-509A
Teiji Kuzuya, Masatoshi Ishigami, Takanori Ito, Yoji Ishizu, Takashi Honda, Tetsuya Ishikawa, Mitsuhiro Fujishiro. Initial Experience of Ramucirumab Treatment After Lenvatinib Failure for Patients With Advanced Hepatocellular Carcinoma. Anticancer research. 2020. 40. 4. 2089-2093
Teiji Kuzuya, Masatoshi Ishigami, Takanori Ito, Yoji Ishizu, Takashi Honda, Tetsuya Ishikawa, Mitsuhiro Fujishiro. Sorafenib vs. Lenvatinib as First-line Therapy for Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis. Anticancer research. 2020. 40. 4. 2283-2290
Teiji Kuzuya, Masatoshi Ishigami, Takanori Ito, Yoji Ishizu, Takashi Honda, Tetsuya Ishikawa, Mitsuhiro Fujishiro. Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology. 2020. 50. 3. 374-381

経歴 (1件)：

- 現在名古屋大学大学院医学系研究科消化器内科助教

所属学会 (4件)：

日本内科学会 , 日本門脈圧亢進症学会 , 日本肝臓学会 , 日本消化器病学会

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

石津 洋二

石津洋二